Abstract
Impaired postprandial gallbladder emptying inceliac disease has been attributed to an absence ofappropriate cholecystokinin release. To determine if aflat jejunal mucosa in celiac patients is related to a reduced cholecystokinin-secretingcapacity, increasing doses of bombesin were infused intosix patients with celiac disease and a flat jejunalmucosa (group A), in seven celiac patients with a normal jejunal mucosa while on a gluten-free diet(group B), and in seven healthy controls (group C).Bombesin induced significant (P < 0.05) increments ofplasma CCK to a maximum value of 1.0 ± 0.3 pM in group A, to 1.5 ± 0.3 pM in group B, andto 1.2 ± 0.3 pM in group C (NS between groups),that were accompanied by significant (P < 0.05)gallbladder emptying responses of 70 ± 4% ingroup A, 47 ± 10% in group B and 65 5% in group C.Dose-response relationships were not different betweengroups. We conclude that there is no major impairment ofgallbladder responsiveness to bombesin or ofcholecystokinin-secreting capacity in patients with a flat jejunal mucosadue to celiac disease.
Similar content being viewed by others
REFERENCES
Mearin ML, Mulder CJJ: Celiac disease (gluten-sensitive enteropathy). InBockus Gastroenterology. WS Haubrich, F Schaffner, JE Berk (eds). Philadelphia, WB Saunders, 1995, pp 1027-1048
Marsh MN: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ( “celiac sprue” ). Gastroenterology 102:330-354, 1992
DiMagno EP, Go VLW, Summerskill WHJ: Impaired cholecystokinin - pancreozymin secretion, intraduodenal dilution, and maldigestion of fat in sprue. Gastroenterology 63:25-32, 1972
Carroccio A, Iacono G, Montalto G, Cavataio F, Lorello D, Soresi M, Di Martino D, Notarbartolo A: Pancreatic insufficiency in celiac disease is not dependent on nutritional status. Dig Dis Sci 39:2235-2242, 1994
Regan PT, DiMagno EP: Exocrine pancreatic insufficiency in celiac sprue: A cause of treatment failure. Gastroenterology 78:484-487, 1980
Jansen JBMJ, Hopman WPM, Rosenbusch G, Lamers CBHW: Plasma cholecystokinin and gallbladder responses to intraduodenal fat and intravenous cholecystokinin in patients with coeliac disease. Eur J Gastroenterol Hepatol 4:349-353, 1992
Masclee AAM, Jansen JBMJ, Driessen WMM, Geuskens LM, Lamers CBHW: Correlation of gallbladder contraction with plasma cholecystokinin-like immunore activity during infusion of cerule in. Scand J Gastroenterol 26:1279-1284, 1991
Brown AM, Bradshaw MJ, Richardson R, Wheeler JG, Harvey RF: Pathogenesis of the impaired gall bladder contraction of coeliac disease. Gut 28:1426-1432, 1987
Maton PN, Selden AC, Fitzpatrick ML, Chadwick VS: Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet. Gastroenterology 88:391-396, 1985
Low-Beer TS, Harvey RF, Davies ER, Read AE: Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease. N Engl J Med 292:961-963, 1975
Calam J, Ellis A, Dockray GJ: Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with coeliac disease. J Clin Invest 69:218-225, 1982
Sjolund K, Alumets J, Berg NO, Hakanson R, Sundler F: Duodenal endocrine cells in adult coeliac disease. Gut 20:547-552, 1979
Polak JM, Bloom SR, McCrossman MV, Timson CM, Johnston DR, Hudson D, Szelze M, Pearse AGE: Cholecystokinin abnormalities in coeliac disease. Gastroenterology 74:1079, 1978 (abstract)
Thimister PWL, Hopman WPM, Sloots CEJ, Rosenbusch G, Tangerman A, Willems HL, Lamers CBHW, Jansen JBMJ: Effect of bile salt binding or protease inactivation on plasma cholecystokinin and gallbladder responses to bombesin. Gastroenterology 107:1627-1635, 1994
Jansen JBMJ, Lamers CBHW: Molecular forms of cholecystokinin in human plasma during infusion of bombesin. Life Sci 33:2197-2205, 1983
Jansen JBMJ, Lamers CBHW: Radioimmunoassay of cholecystokinin: Production and evaluation of antibodies. J Clin Chem Clin Biochem 21:387-394, 1983
Jansen JBMJ, Lamers CBHW: Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 131:305-316, 1983
Everson GT, Braverman DZ, Johnson ML, Kern F: A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79:40-46, 1980
Hopman WPM, Brouwer WFM, Rosenbusch G, Jansen JBMJ, Lamers CBHW: A computerized method for rapid quantification of gallbladder volume from real-time sonograms. Radiology 154:236-237, 1985
Elashoff JD: Down with multiple t-tests! Gastroenterology 80:615-620, 1981
Hopman WPM, Rosenbusch G, Hectors MPC, Jansen JBMJ: Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gallbladder motility in coeliac disease. Gut 36:17-21, 1995
Thimister PWL, Hopman WPM, Sloots CEJ, Rosenbusch G, Willems HL, Trijbels FJM, Jansen JBMJ: Role of intraduodenal proteases in plasma cholecystokinin and pancreaticobiliary responses to protein and amino acids. Gastroenterology 110:567-575, 1996
Welton ML, Mantyh CR, Gates TS, Popper P, Vigna SR, Maggio JE, Passaro E, Mantyh PW: Localization of bombesin receptors in human gastrointestinal tract using quantitative receptor autoradiography. Regul Pept 19:144-145, 1987 (abstract)
Schjoldager B, Poulsen SS, Schmidt P, Coy DH, Holst JJ: Gastrin-releasing peptide is a transmitter mediating porcine gallbladder contraction. Am J Physiol 260:G577-G585, 1991
Rouissi N, Rhaleb NE, Nantel F, Dion S, Drapeau G, Regoli D: Characterization of bombesin receptors in peripheral contractile organs. Br J Pharmacol 103:1141-1147, 1991
Severi C, Grider JR, Makhlouf GM: Identification of separate bombesin and substance Preceptors on isolated muscle cells from canine gallbladder. J Pharmacol Exp Ther 245:195-198, 1988
Parkman HP, Vozzelli MA, Pagano AP, Cowan A: Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle. Regul Pept 52:173-180, 1994
Mitsukawa T, Takemura J, Nishizono F, Nakatsuru K, Ohgo S, Matsukura S: Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction. Am J Gastroenterol 84:1371-1374, 1989
Douglas BR, Jebbink MCW, Tjon A, Tham RTO, Jansen JBMJ, Lamers CBHW: The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man. Eur J Pharmacol 166:307-309, 1989
Jebbink MCW, Jansen JBMJ, Mooy DM, Rovati LC, Lamers CBHW: Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man. Regul Pept 32:361-368, 1991
Braganza J, Howatt HT: Gallbladder inertia in celiac disease. Lancet 1:1133, 1971
Colombato LO, Parodi H, Cantor D: Biliary function studies in patients with celiac sprue. Am J Dig Dis 22:96-98, 1977
Rights and permissions
About this article
Cite this article
Thimister, P.W.L., Hopman, W.P.M., Rosenbusch, G. et al. Plasma Cholecystokinin and Gallbladder Responses to Increasing Doses of Bombesin in Celiac Disease. Dig Dis Sci 43, 668–672 (1998). https://doi.org/10.1023/A:1018844031460
Issue Date:
DOI: https://doi.org/10.1023/A:1018844031460